Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Open-Label Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

NCT03642210 is registered in ClinicalTrials.gov with Medicines360 as lead sponsor.

NCT NCT03642210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03642210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Open-Label Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
Lead sponsor
Medicines360
Phase
Phase 3
Overall status
Completed
Start date
January 17, 2019
Completion date
October 12, 2021
Enrollment
105 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

menorrhagia